Zacks Investment Research on MSN3h
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What ...
William Blair cut their Q1 2025 earnings per share (EPS) estimates for Arcturus Therapeutics in a report issued on Thursday, March 13th. William Blair analyst M. Minter now forecasts that the ...
24/7 Wall St. on MSN21m
Could Preferred Stock ETFs Be the Secret to Stable Income?Income-based investors often devote a large part of their securities research time looking at bonds. dividend stocks, REITs, ...
Daiwa Securities Group Inc. lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 165.5% during the fourth ...
Press Release4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 ...
The deal includes the Belgian biotech’s vivo cell-therapy platform, which modifies immune cells within the patient’s body, ...
Broadcom's Q1 2025 results show $15B revenue and 25% FCF growth. Strong AI, semiconductor focus, and dividends drive value ...
EsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca ( NASDAQ: AZN) for up to $1 billion, on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback